Works about IMATINIB


Results: 3278
    1

    3D-QSAR Design of New Bcr-Abl Inhibitors Based on Purine Scaffold and Cytotoxicity Studies on CML Cell Lines Sensitive and Resistant to Imatinib.

    Published in:
    Pharmaceuticals (14248247), 2025, v. 18, n. 6, p. 925, doi. 10.3390/ph18060925
    By:
    • Cabezas, David;
    • Delgado, Thalía;
    • Sepúlveda, Guisselle;
    • Krňávková, Petra;
    • Vojáčková, Veronika;
    • Kryštof, Vladimír;
    • Strnad, Miroslav;
    • Silva, Nicolás Ignacio;
    • Echeverría, Javier;
    • Espinosa-Bustos, Christian;
    • Mellado, Guido;
    • Luo, Jiao;
    • Mella, Jaime;
    • Salas, Cristian O.
    Publication type:
    Article
    2
    3
    4
    5
    6
    7

    Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG).

    Published in:
    Journal of Neuro-Oncology, 2019, v. 143, n. 3, p. 573, doi. 10.1007/s11060-019-03194-z
    By:
    • Jaeckle, Kurt A.;
    • Anderson, S. K.;
    • Twohy, Erin L.;
    • Dixon, Jesse G.;
    • Giannini, Caterina;
    • Jenkins, Robert;
    • Egorin, Merrill J.;
    • Sarkaria, Jann N.;
    • Brown, Paul D.;
    • Flynn, P. J.;
    • Schwerkoske, John;
    • Buckner, Jan C.;
    • Galanis, Evanthia
    Publication type:
    Article
    8
    9
    10
    11

    KIT expression and methylation in medulloblastoma and PNET cell lines and tumors.

    Published in:
    Journal of Neuro-Oncology, 2011, v. 103, n. 2, p. 247, doi. 10.1007/s11060-010-0391-6
    By:
    • Enguita-Germán, Mónica;
    • Gurrea, Mikel;
    • Schiapparelli, Paula;
    • Zhu, Thant;
    • Crowley, Jessica;
    • Hamm, Lisa;
    • Costello, Mark;
    • He, Xiaobing;
    • Talsma, Caroline;
    • Flack, Callie;
    • Hervey-Jumper, Shawn;
    • Heth, Jason;
    • Muraszko, Karin;
    • Rey, Juan;
    • Fan, Xing;
    • Castresana, Javier
    Publication type:
    Article
    12
    13
    14
    15
    16
    17

    Imatinib in combination with hydroxyurea versus hydroxyurea alone as oral therapy in patients with progressive pretreated glioblastoma resistant to standard dose temozolomide.

    Published in:
    Journal of Neuro-Oncology, 2010, v. 96, n. 3, p. 393, doi. 10.1007/s11060-009-9976-3
    By:
    • Dresemann, Gregor;
    • Weller, Michael;
    • Rosenthal, Mark A.;
    • Wedding, Ulrich;
    • Wagner, Wolfgang;
    • Engel, Erik;
    • Heinrich, Bernhard;
    • Mayer-Steinacker, Regine;
    • Karup-Hansen, Anders;
    • Fluge, Øystein;
    • Nowak, Anna;
    • Mehdorn, Maximilian;
    • Schleyer, Eberhard;
    • Krex, Dietmar;
    • Olver, Ian N.;
    • Steinbach, Joachim P.;
    • Hosius, Christian;
    • Sieder, Christian;
    • Sorenson, Greg;
    • Parker, Richard
    Publication type:
    Article
    18
    19
    20
    22
    23

    Clinical significance of surgical intervention for imatinib-resistant gastrointestinal stromal tumors in the era of multiple tyrosine kinase inhibitors.

    Published in:
    Surgery Today, 2021, v. 51, n. 9, p. 1506, doi. 10.1007/s00595-021-02241-5
    By:
    • Wada, Noriko;
    • Takahashi, Tsuyoshi;
    • Kurokawa, Yukinori;
    • Nakajima, Kiyokazu;
    • Nishida, Toshirou;
    • Koh, Masahiro;
    • Akamaru, Yusuke;
    • Motoori, Masaaki;
    • Kimura, Yutaka;
    • Tanaka, Koji;
    • Miyazaki, Yasuhiro;
    • Makino, Tomoki;
    • Yamasaki, Makoto;
    • Eguchi, Hidetoshi;
    • Doki, Yuichiro
    Publication type:
    Article
    24

    Neoadjuvant imatinib therapy in rectal gastrointestinal stromal tumors.

    Published in:
    Surgery Today, 2019, v. 49, n. 6, p. 460, doi. 10.1007/s00595-018-1737-5
    By:
    • Kaneko, Manabu;
    • Emoto, Shigenobu;
    • Murono, Koji;
    • Sonoda, Hirofumi;
    • Hiyoshi, Masaya;
    • Sasaki, Kazuhito;
    • Shuno, Yasutaka;
    • Nishikawa, Takeshi;
    • Tanaka, Toshiaki;
    • Hata, Keisuke;
    • Kawai, Kazushige;
    • Nozawa, Hiroaki
    Publication type:
    Article
    25
    26

    Giant esophageal gastrointestinal stromal tumor: report of a case.

    Published in:
    Surgery Today, 2015, v. 45, n. 2, p. 247, doi. 10.1007/s00595-014-0929-x
    By:
    • Nakano, Akira;
    • Akutsu, Yasunori;
    • Shuto, Kiyohiko;
    • Uesato, Masaya;
    • Kono, Tsuguaki;
    • Hoshino, Isamu;
    • Akanuma, Naoki;
    • Maruyama, Tetsuro;
    • Isozaki, Yuka;
    • Matsubara, Hisahiro
    Publication type:
    Article
    27
    28
    29
    30
    31
    32
    33

    Current Therapies for Chronic Myeloid Leukemia.

    Published in:
    Journal of Pharmacy Practice, 2008, v. 21, n. 2, p. 116, doi. 10.1177/0897190008314778
    By:
    • Kenealy, Laureen K.;
    • Christenson, Courtney B.;
    • Williams, Casey B.
    Publication type:
    Article
    34
    35

    Tumeurs stromales du tube digestif (GIST).

    Published in:
    Oncologie (Tech Science Press), 2007, v. 9, n. 2, p. 144, doi. 10.1007/s10269-006-0552-6
    By:
    • Bui, B. -N.;
    • Stöeckle, E.;
    • Kind, M.;
    • Coindre, J. -M.
    Publication type:
    Article
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49

    The Role of Imatinib in Pediatric Type 1 Diabetes.

    Published in:
    JCEM Case Reports, 2024, v. 2, n. 5, p. 1, doi. 10.1210/jcemcr/luae065
    By:
    • Lavelle, Kristen;
    • Chamberlain, Chester;
    • German, Michael;
    • Anderson, Mark;
    • Nip, Angel;
    • Gitelman, Stephen E
    Publication type:
    Article
    50